GENEVA (AP) -- Swiss drug maker Novartis AG says it has received European approval to market Afinitor for treatment of women with the most common form of advanced breast cancer....
Associated Press: Health
Mon, 07/30/2012 - 7:37am
GENEVA (AP) -- Swiss drug maker Novartis AG says it has received European approval to market Afinitor for treatment of women with the most common form of advanced breast cancer....